Nexalin Technology Inc (NXL)
0.7075
-0.02
(-2.33%)
USD |
NASDAQ |
May 31, 16:00
0.7075
0.00 (0.00%)
After-Hours: 20:00
Nexalin Technology Debt to Equity Ratio: 0.00 for March 31, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.1545 |
| June 30, 2023 | 0.1252 |
| March 31, 2023 | 0.1056 |
| Date | Value |
|---|---|
| December 31, 2022 | 0.1278 |
| September 30, 2022 | 0.1102 |
| June 30, 2022 | -0.3246 |
| March 31, 2022 | -0.3828 |
| December 31, 2021 | -0.4519 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-0.4519
Minimum
Dec 2021
0.1545
Maximum
Sep 2023
-0.0536
Average
0.0528
Median
Debt to Equity Ratio Benchmarks
| Envoy Medical Inc | 0.00 |
| Ainos Inc | 0.2505 |
| OpGen Inc | 3.437 |
| Zomedica Corp | 0.00 |
| LENSAR Inc | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 2.834M |
| Total Liabilities (Quarterly) | 0.5072M |
| Shareholders Equity (Quarterly) | 2.327M |
| Current Ratio | 5.054 |
| Net Debt Paydown Yield | 1.34% |